SEC Form 4 · accession 0001562180-16-002105
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Paul
Director
Period of report
Feb 23, 2016
Accepted (ET)
Apr 5, 2016 · 7:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2016 | G | 847 | $0.00 | D | 682,803 | I | Eli D. Fisch 2015 Irrevocable Trust (Grandson) |
| Common Stock | Feb 23, 2016 | G | 847 | $0.00 | D | 681,956 | I | Benjamin T. Fisch 2015 Irrevocable Trust (Grandson) |
| Common Stock | Feb 23, 2016 | G | 847 | $0.00 | D | 681,109 | I | Lila M. Clair 2015 Irrevocable Trust (Granddaughter) |
| Common Stock | Feb 23, 2016 | G | 423 | $0.00 | D | 680,686 | I | Austin Tyler Paul ( Daughter) |
| Common Stock | Feb 23, 2016 | G | 847 | $0.00 | D | 679,839 | I | Aaron and Hannah Paul (Son and daughter in law) |
| Common Stock | Feb 23, 2016 | G | 847 | $0.00 | D | 678,992 | I | Jordan and Mark Fisch (Daughter and son in law) |
| Common Stock | Feb 23, 2016 | G | 423 | $0.00 | D | 678,569 | I | Morgan E. McGill (Daughter) |
Table II — derivative securities
No Table II lines on this filing.